Jared Robbins, MD
Jared Robbins, MD
Residency Program Director
Contact Information
Background
Dr Robbins completed his medical degree at the University of Arizona, college of Medicine, then went the prestigious Henry Ford Hospital for his residency training and for the past 5 years he has been on the staff at the Medical College of Wisconsin where he achieved national and international reputation, publishing 30 peer reviewed publications and numerous abstracts at meetings. He is regarded as an exceptional teacher and was awarded accolades for his residents/medical student teachings. He will be treating Head & Neck cancer, Skin cancers and brain metastases in addition to starting a program for spinal SBRT.
2011 Travel Grant, American Radium Society
2011 Roentgen Resident/Fellow Research Award, Radiological Society of North America
2012 Runner-up in Michigan State Medical Society Resident Research Competition
2012 Oncology Trainee Travel Award from the Conquer Cancer Foundation of ASCO
2012 2nd Prize, 19th Annual Resident & Fellow Research Forum, Henry Ford Hospital
2012 Roentgen Resident/Fellow Research Award, Radiological Society of North America
2012 2nd Prize, 35th Annual Southeastern Michigan Center for Medical Education, Oral Research Competition
2013 Finalist in Michigan State Radiological Society Resident Research Competition
2016 ARRO Educator of the Year Award
2016 Second Place for Junior Faculty Non-Basic Science Research, Annual Medical College of Wisconsin Research Day
2016 Runner-up in Overall Highest Patient Satisfaction Scores for all Outpatient Oncology in all the MCW/Froedtert Heath System
2012 Runner-up in Michigan State Medical Society Resident Research Competition
2012 Oncology Trainee Travel Award from the Conquer Cancer Foundation of ASCO
2012 2nd Prize, 19th Annual Resident & Fellow Research Forum, Henry Ford Hospital
2012 Roentgen Resident/Fellow Research Award, Radiological Society of North America
2012 2nd Prize, 35th Annual Southeastern Michigan Center for Medical Education, Oral Research Competition
2013 Finalist in Michigan State Radiological Society Resident Research Competition
2016 ARRO Educator of the Year Award
2016 Second Place for Junior Faculty Non-Basic Science Research, Annual Medical College of Wisconsin Research Day
2016 Runner-up in Overall Highest Patient Satisfaction Scores for all Outpatient Oncology in all the MCW/Froedtert Heath System
Education
Research
Noid G, TAi A, Chen GP, Robbins J, Li XA, Reducing Radiation Dose and Enhancing Imaging Quality of 4DCT for Radiation Therapy Using Iterative Reconstruction Algorithms, Advances in Radiation Oncology (2017),doi:10.1016/j.adro.2017.04.003. PMID:29114620
Schmid RK, Harker-Murray A, Niemsczyk, Robbins JR. Diffuse recurrent cutaneous melanoma of the scalp and neck successfully treated with volumetric modulated arc therapy and concurrent Ipilimumab. Practical Radiation Oncology. 2018 May-June; 8(3):174-178. PMID:29122555
Wu H, Chen X, Yang X, Tao Y, Xia Y, Deng X, Zheng C, Robbins J, Schultz C, Li XA. Early Prediction of Acute Xerostomia during Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT, International Journal of Radiation Oncology, Biology, Physics. 2018 May 1 (epub ahead of print). PMID:29891201
Noid G, Tai A, Mistry N, Liu Y, Schmidt TG, Robbins JR, Li XA. Technical Note: Enhancing soft tissue contrast and radiation induced image changes with dual-energy CT for radiation therapy. Medical Physic, 2018 Jul 4 (epub ahead of print). PMID:29972868
Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke J-J, van der Heide UA, Nutting C, Li AX, Robbins JR, Awan M, and Fuller CD. Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clinical and Translational Radiation Oncology. 2018 Nov(13):19-23. PMID:30386824
Robbins JR, Schmid RK, Hammad AY, Gamblin TC, Erickson BA. Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival. Cancer Med. 2019 Mar;8(3):928-938. PMID:30701703
Robbins JR, Kilari D, Johnston F. Palliative care education for oncologists: how are we doing? Ann Palliat Med. 2019 Mar 28. PMID:30943741
Wong M, Kim J, George B, Eriksen C, Pearson T, Robbins J, Zimmerman MA, Hong JC. Downstaging locally advanced cholangiocarcinoma pre-liver transplantation: a prospective pilot study. J Surg Res. 2019 May 3;242-23-30. PMID:31059945
Schmid RK, Tai A, Klawikowski S, Straza M, Ramahi K, Li XA, Robbins JR. The Dosimetric Impact of Interfractional Organ-at-Risk Movement During Liver Stereotactic Body Radiation Therapy. Pract Radiat Oncol. 2019 Jun 6 (Epub ahead of print). PMID:31176791
Han JE, Yi SK, Wang S, Erman A, Bearelly S, Sindhu S, Robbins JR, Bauman J, Hsu CC. Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease. Head Neck. 2019 Sep 14. PMID:31520512
Clinical Studies
Title |
Description | Cancer Area | Cancer Type | Trial Status |
|---|---|---|---|---|
| 1805527255 |
NCT03509012 Phase I Multicenter Study of Immunotherapy in Combination with Chemoradiation in Patients with Advanced Solid Tumors (CLOVER) |
|||
| A091802 |
NCT03944941 Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin (cSCC) |
|||
| EA3132 |
NCT02734537 Phase II Randomized Trial of Adjuvant Radiotherapy with or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) |
|||
| NRG-HN005 |
NCT03952585: A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients with Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer |
Current Trial Enrolling | ||
| RTOG 3507 |
NCT03546582 A Randomized Phase II Study of Pembrolizumab (Keytruda) plus Stereotactic Re-irradiation versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma |
|||
| RTOG 3507 |
NCT03546582 A Randomized Phase II Study of Pembrolizumab (Keytruda) plus Stereotactic Re-irradiation versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma |
|||
| RTOG 3507 |
NCT03546582 A Randomized Phase II Study of Pembrolizumab (Keytruda) plus Stereotactic Re-irradiation versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma |
|||
| RTOG-1008 |
NCT01220583: A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors |